Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Triglyceride deposit cardiomyovasculopathy: a rare cardiovascular disorder.

Li M, Hirano KI, Ikeda Y, Higashi M, Hashimoto C, Zhang B, Kozawa J, Sugimura K, Miyauchi H, Suzuki A, Hara Y, Takagi A, Ikeda Y, Kobayashi K, Futsukaichi Y, Zaima N, Yamaguchi S, Shrestha R, Nakamura H, Kawaguchi K, Sai E, Hui SP, Nakano Y, Sawamura A, Inaba T, Sakata Y, Yasui Y, Nagasawa Y, Kinugawa S, Shimada K, Yamada S, Hao H, Nakatani D, Ide T, Amano T, Naito H, Nagasaka H, Kobayashi K; Japan TGCV study group.

Orphanet J Rare Dis. 2019 Jun 11;14(1):134. doi: 10.1186/s13023-019-1087-4.

2.

Genetic mutations in adipose triglyceride lipase and myocardial up-regulation of peroxisome proliferated activated receptor-γ in patients with triglyceride deposit cardiomyovasculopathy.

Hirano K, Tanaka T, Ikeda Y, Yamaguchi S, Zaima N, Kobayashi K, Suzuki A, Sakata Y, Sakata Y, Kobayashi K, Toda T, Fukushima N, Ishibashi-Ueda H, Tavian D, Nagasaka H, Hui SP, Chiba H, Sawa Y, Hori M.

Biochem Biophys Res Commun. 2014 Jan 10;443(2):574-9. doi: 10.1016/j.bbrc.2013.12.003. Epub 2013 Dec 8.

PMID:
24332944
3.

Newly developed selective immunoinactivation assay revealed reduction in adipose triglyceride lipase activity in peripheral leucocytes from patients with idiopathic triglyceride deposit cardiomyovasculopathy.

Takagi A, Ikeda Y, Kobayashi K, Kobayashi K, Ikeda Y, Kozawa J, Miyauchi H, Li M, Hashimoto C, Hara Y, Yamaguchi S, Suzuki A, Toda T, Nagasaka H, Hirano KI.

Biochem Biophys Res Commun. 2018 Jan 1;495(1):646-651. doi: 10.1016/j.bbrc.2017.11.070. Epub 2017 Nov 13.

PMID:
29146190
4.

Tricaprin Rescues Myocardial Abnormality in a Mouse Model of Triglyceride Deposit Cardiomyovasculopathy.

Suzuki A, Yamaguchi S, Li M, Hara Y, Miyauchi H, Ikeda Y, Zhang B, Higashi M, Ikeda Y, Takagi A, Nagasaka H, Kobayashi K, Magata Y, Aoyama T, Hirano KI.

J Oleo Sci. 2018 Aug 1;67(8):983-989. doi: 10.5650/jos.ess18037. Epub 2018 Jul 17.

5.

A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review.

Kaneko K, Kuroda H, Izumi R, Tateyama M, Kato M, Sugimura K, Sakata Y, Ikeda Y, Hirano K, Aoki M.

Neuromuscul Disord. 2014 Jul;24(7):634-41. doi: 10.1016/j.nmd.2014.04.001. Epub 2014 Apr 21. Review.

PMID:
24836204
6.

Quantitative proteomic analysis of cultured skin fibroblast cells derived from patients with triglyceride deposit cardiomyovasculopathy.

Hara Y, Kawasaki N, Hirano K, Hashimoto Y, Adachi J, Watanabe S, Tomonaga T.

Orphanet J Rare Dis. 2013 Dec 21;8:197. doi: 10.1186/1750-1172-8-197.

7.

[Triglyceride deposit cardiomyovasculopathy].

Hirano K.

Nihon Rinsho. 2013 Sep;71(9):1676-80. Review. Japanese.

PMID:
24205734
8.

Peripheral leukocyte anomaly detected with routine automated hematology analyzer sensitive to adipose triglyceride lipase deficiency manifesting neutral lipid storage disease with myopathy/triglyceride deposit cardiomyovasculopathy.

Suzuki A, Nagasaka H, Ochi Y, Kobayashi K, Nakamura H, Nakatani D, Yamaguchi S, Yamaki S, Wada A, Shirata Y, Hui SP, Toda T, Kuroda H, Chiba H, Hirano KI.

Mol Genet Metab Rep. 2014 May 27;1:249-253. eCollection 2014.

9.

Impact of diabetes mellitus on myocardial lipid deposition: an autopsy study.

Nakanishi T, Kato S.

Pathol Res Pract. 2014 Dec;210(12):1018-25. doi: 10.1016/j.prp.2014.04.008. Epub 2014 Apr 23.

PMID:
24836730
10.

Reduced expression of adipose triglyceride lipase enhances tumor necrosis factor alpha-induced intercellular adhesion molecule-1 expression in human aortic endothelial cells via protein kinase C-dependent activation of nuclear factor-kappaB.

Inoue T, Kobayashi K, Inoguchi T, Sonoda N, Fujii M, Maeda Y, Fujimura Y, Miura D, Hirano K, Takayanagi R.

J Biol Chem. 2011 Sep 16;286(37):32045-53. doi: 10.1074/jbc.M111.285650. Epub 2011 Aug 2.

11.

Downregulation of adipose triglyceride lipase in the heart aggravates diabetic cardiomyopathy in db/db mice.

Inoue T, Kobayashi K, Inoguchi T, Sonoda N, Maeda Y, Hirata E, Fujimura Y, Miura D, Hirano K, Takayanagi R.

Biochem Biophys Res Commun. 2013 Aug 16;438(1):224-9. doi: 10.1016/j.bbrc.2013.07.063. Epub 2013 Jul 22.

PMID:
23886955
12.

A novel clinical entity: triglyceride deposit cardiomyovasculopathy.

Hirano K.

J Atheroscler Thromb. 2009 Oct;16(5):702-5. Epub 2009 Sep 3.

13.

Coronary triglyceride deposition in contemporary advanced diabetics.

Ikeda Y, Zaima N, Hirano K, Mano M, Kobayashi K, Yamada S, Yamaguchi S, Suzuki A, Kanzaki H, Hamasaki T, Kotani J, Kato S, Nagasaka H, Setou M, Ishibashi-Ueda H.

Pathol Int. 2014 Jul;64(7):325-35. doi: 10.1111/pin.12177.

PMID:
25047503
14.

Long-chain fatty acid triglyceride (TG) metabolism disorder impairs male fertility: a study using adipose triglyceride lipase deficient mice.

Masaki H, Kim N, Nakamura H, Kumasawa K, Kamata E, Hirano KI, Kimura T.

Mol Hum Reprod. 2017 Jul 1;23(7):452-460. doi: 10.1093/molehr/gax031.

PMID:
28510703
15.

Of mice and men: The physiological role of adipose triglyceride lipase (ATGL).

Schreiber R, Xie H, Schweiger M.

Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jun;1864(6):880-899. doi: 10.1016/j.bbalip.2018.10.008. Epub 2018 Oct 25. Review.

16.

Neutral lipid storage disease: genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5.

Schweiger M, Lass A, Zimmermann R, Eichmann TO, Zechner R.

Am J Physiol Endocrinol Metab. 2009 Aug;297(2):E289-96. doi: 10.1152/ajpendo.00099.2009. Epub 2009 Apr 28. Review.

17.

Human adipose triglyceride lipase (PNPLA2) is not regulated by obesity and exhibits low in vitro triglyceride hydrolase activity.

Mairal A, Langin D, Arner P, Hoffstedt J.

Diabetologia. 2006 Jul;49(7):1629-36. Epub 2006 May 10.

PMID:
16752181
18.

Novel missense mutations in PNPLA2 causing late onset and clinical heterogeneity of neutral lipid storage disease with myopathy in three siblings.

Missaglia S, Tasca E, Angelini C, Moro L, Tavian D.

Mol Genet Metab. 2015 Jun-Jul;115(2-3):110-7. doi: 10.1016/j.ymgme.2015.05.001. Epub 2015 May 2.

19.

Distinct cardiac phenotype between two homozygotes born in a village with accumulation of a genetic deficiency of adipose triglyceride lipase.

Higashi M, Hirano K, Kobayashi K, Ikeda Y, Issiki A, Otsuka T, Suzuki A, Yamaguchi S, Zaima N, Hamada S, Hanada H, Suzuki C, Nakamura H, Nagasaka H, Miyata T, Miyamoto Y, Kobayashi K, Naito H, Toda T.

Int J Cardiol. 2015 Aug 1;192:30-2. doi: 10.1016/j.ijcard.2015.05.004. Epub 2015 May 6. No abstract available.

PMID:
25985012
20.

Downregulation of adipose triglyceride lipase promotes cardiomyocyte hypertrophy by triggering the accumulation of ceramides.

Gao H, Feng XJ, Li ZM, Li M, Gao S, He YH, Wang JJ, Zeng SY, Liu XP, Huang XY, Chen SR, Liu PQ.

Arch Biochem Biophys. 2015 Jan 1;565:76-88. doi: 10.1016/j.abb.2014.11.009. Epub 2014 Nov 28.

PMID:
25436917

Supplemental Content

Support Center